Skip to Main Content

Author Details

Michelle Whirl-Carrillo
Stanford University
1995
94
45
PMIDPaper TitleJournal TitlePublished Year
36049896Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype.Clin Pharmacol Ther2023
37669183PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on Reporting.Clin Pharmacol Ther2023
37757824Frequencies of pharmacogenomic alleles across biogeographic groups in a large-scale biobank.Am J Hum Genet2023
37728645PharmGKB summary: disulfiram pathway.Pharmacogenet Genomics2023
37303270An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers.Clin Pharmacol Ther2023
36350094How to Run the Pharmacogenomics Clinical Annotation Tool (PharmCAT).Clin Pharmacol Ther2023
34032273Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT-RNR1 Genotype.Clin Pharmacol Ther2022
35665708PharmGKB summary: acyclovir/ganciclovir pathway.Pharmacogenet Genomics2022
36443877Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.J Transl Med2022
35102073PharmGKB summary: heparin-induced thrombocytopenia pathway, adverse drug reaction.Pharmacogenet Genomics2022
34890165An Investigation of the Knowledge Overlap between Pharmacogenomics and Disease Genetics.Pac Symp Biocomput2022
35202484PharmVar GeneFocus: CYP3A5.Clin Pharmacol Ther2022
32779747Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update.Clin Pharmacol Ther2021
34387941PharmGKB, an Integrated Resource of Pharmacogenomic Knowledge.Curr Protoc2021
34216021An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine.Clin Pharmacol Ther2021
34318925Advancing Precision Medicine Through the New Pharmacogenomics Global Research Network.Clin Pharmacol Ther2021
34118403Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy.J Mol Diagn2021
34091888Pharmacogene Variation Consortium: A Global Resource and Repository for Pharmacogene Variation.Clin Pharmacol Ther2021
34109627PharmVar GeneFocus: CYP2C9.Clin Pharmacol Ther2021
33448339PharmVar GeneFocus: CYP2B6.Clin Pharmacol Ther2021
33237584Pharmacogenetics at Scale: An Analysis of the UK Biobank.Clin Pharmacol Ther2021
33070160Pharmacogenetic information in Swiss drug labels - a systematic analysis.Pharmacogenomics J2021
32602114PharmVar GeneFocus: CYP2C19.Clin Pharmacol Ther2021
32978778PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID-19.Clin Pharmacol Ther2021
31562822The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later.Clin Pharmacol Ther2020
31758698PharmVar and the Landscape of Pharmacogenetic Resources.Clin Pharmacol Ther2020
31647186Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group.Clin Transl Sci2020
31797632PGxMine: Text mining for curation of PharmGKB.Pac Symp Biocomput2020
33142667Variant Interpretation in Current Pharmacogenetic Testing.J Pers Med2020
33137098Transfer learning enables prediction of CYP2D6 haplotype function.PLoS Comput Biol2020
32407955Response to: Unveiling the guidance heterogeneity for genome-informed drug treatment interventions among regulatory bodies and research consortia.Pharmacol Res2020
32380173Recommendations for Clinical Warfarin Genotyping Allele Selection: A Report of the Association for Molecular Pathology and the College of American Pathologists.J Mol Diagn2020
31544239PharmVar GeneFocus: CYP2D6.Clin Pharmacol Ther2020
31306493Pharmacogenomics Clinical Annotation Tool (PharmCAT).Clin Pharmacol Ther2020
30406943Essential Characteristics of Pharmacogenomics Study Publications.Clin Pharmacol Ther2019
30977517Are Randomized Controlled Trials Necessary to Establish the Value of Implementing Pharmacogenomics in the Clinic?Clin Pharmacol Ther2019
31006110Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-Containing Antiretroviral Therapy.Clin Pharmacol Ther2019
31075510Recommendations for Clinical CYP2C9 Genotyping Allele Selection: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists.J Mol Diagn2019
30515762Pharmacogene Variation Consortium Gene Introduction: NUDT15.Clin Pharmacol Ther2019
30447069Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update.Clin Pharmacol Ther2019
30536702The Evolution of PharmVar.Clin Pharmacol Ther2019
30506572Standardized Biogeographic Grouping System for Annotating Populations in Pharmacogenetic Research.Clin Pharmacol Ther2019
28994452Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group.Clin Pharmacol Ther2018
29914287Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.Pharmacogenomics2018
29392710Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update.Clin Pharmacol Ther2018
29474005PharmGKB: A worldwide resource for pharmacogenomic information.Wiley Interdiscip Rev Syst Biol Med2018
29635477Pharmacogenomics and big genomic data: from lab to clinic and back again.Hum Mol Genet2018
29385237Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy.Clin Pharmacol Ther2018
29134625The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database.Clin Pharmacol Ther2018
27441996Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC).Genet Med2017
  • 1 - 50 of 94

Recommended Authors

Emily J Cicali
Department of Pharmacotherapy and Translational Research, University of Florida
Career Start Year 2019
Number of shared co-authors 15
Lang Li
College of Medicine, The Ohio State University
Career Start Year 2018
Number of shared co-authors 2
Heidi E Steiner
Data Science Institute, University of Arizona
Career Start Year 2017
Number of shared co-authors 6
Aniwaa Owusu Obeng
Icahn School of Medicine at Mount Sinai
Career Start Year 2014
Number of shared co-authors 38
Nihal El Rouby
Department of Pharmacy Practice and Administrative Sciences, University of Cincinnati
Career Start Year 2013
Number of shared co-authors 22
Omri Gottesman
Icahn School of Medicine at Mount Sinai
Career Start Year 2011
Number of shared co-authors 21
Andrea H Ramirez
Vanderbilt University Medical Center
Career Start Year 2010
Number of shared co-authors 32
Lisa Bastarache
Vanderbilt University Medical Center
Career Start Year 2009
Number of shared co-authors 24
Nicholas P Tatonetti
Columbia Universtiy College of Physicians and Surgeons
Career Start Year 2009
Number of shared co-authors 22
Adam S Gordon
Northwestern University Feinberg School of Medicine.
Career Start Year 2008
Number of shared co-authors 22
Catharina Scholl
Federal Institute for Drugs and Medical Devices (BfArM)
Career Start Year 2008
Number of shared co-authors 1
Terrie Kitchner
Center for Precision Medicine Research, Marshfield Clinic Research Institute
Career Start Year 2007
Number of shared co-authors 18
Michael Steffens
Federal Institute for Drugs and Medical Devices (BfArM)
Career Start Year 2005
Number of shared co-authors 2
Wei-Qi Wei
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 24
Christian M Shaffer
Vanderbilt University
Career Start Year 2004
Number of shared co-authors 29
Scott J Hebbring
Marshfield Clinic Research Institute
Career Start Year 2003
Number of shared co-authors 20
Thomas J Urban
Eshelman School of Pharmacy, University of North Carolina
Career Start Year 2003
Number of shared co-authors 3
Lang Li
Harbin Medical University
Career Start Year 2002
Number of shared co-authors 6
Mathieu Wiepert
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 7
Alison A Motsinger-Reif
National Institute of Environmental Health Sciences
Career Start Year 2002
Number of shared co-authors 19
Sara L Van Driest
National Institutes of Health
Career Start Year 2002
Number of shared co-authors 39
Doug Stryke
University of California San Francisco
Career Start Year 2002
Number of shared co-authors 8
Noura S Abul-Husn
Institute for Genomic Health, Icahn School of Medicine at Mount Sinai
Career Start Year 2002
Number of shared co-authors 20
Gregory D Jenkins
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 11
Alison F Davis
Yale University
Career Start Year 2001
Number of shared co-authors 0
Linnea M Baudhuin
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 7
Lara M Mangravite
Children's Hospital Oakland Research Institute
Career Start Year 1998
Number of shared co-authors 10
Michael R Barnes
William Harvey Research Institute, Queen Mary University of London
Career Start Year 1997
Number of shared co-authors 15
Deanna L Kroetz
University of California San Francisco
Career Start Year 1993
Number of shared co-authors 22
Geoffrey S Ginsburg
National Institutes of Health
Career Start Year 1981
Number of shared co-authors 32

Collaborators

Teri E Klein
Stanford University
Co-authored papers 80
Russ B Altman
Stanford University
Co-authored papers 37
Li Gong
Stanford University
Co-authored papers 16
Mary V Relling
Departments of Pharmaceutical Sciences.
Co-authored papers 15
Stuart A Scott
Stanford University
Co-authored papers 13
Victoria M Pratt
Indiana University School of Medicine
Co-authored papers 9
Larisa H Cavallari
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 7
Matthias Schwab
and of Biochemistry and Pharmacy, University of Tuebingen
Co-authored papers 7
James M Hoffman
St. Jude Children's Research Hospital Memphis
Co-authored papers 7
Ellen M McDonagh
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 7
Howard L McLeod
Center for Precision Medicine and Functional Genomics, Utah Tech University
Co-authored papers 6
Robert R Freimuth
Center for Individualized Medicine, Mayo Clinic
Co-authored papers 6
Charles M Stein
Vanderbilt University School of Medicine
Co-authored papers 6
Cyrine E Haidar
St. Jude Children's Research Hospital
Co-authored papers 5
Marylyn D Ritchie
Center for Systems Genomics, Pennsylvania State University, University Park
Co-authored papers 5
Julie A Johnson
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 5
Euan A Ashley
Stanford University
Co-authored papers 4
Frederick E Dewey
Co-authored papers 4
Binglan Li
Stanford University
Co-authored papers 4
Michael Snyder
Stanford University
Co-authored papers 4
Mark J Ratain
University of Chicago
Co-authored papers 4
Ching-Hon Pui
St. Jude Children's Research Hospital
Co-authored papers 4
Sean P David
Co-authored papers 4
William E Evans
Departments of Oncology. St. Jude Children's Research Hospital
Co-authored papers 4
Josh F Peterson
Vanderbilt University Medical Center
Co-authored papers 4
Kristine R Crews
St. Jude Children's Research Hospital
Co-authored papers 4
Atul J Butte
Bakar Computational Health Sciences Institute, University of California san francisco
Co-authored papers 3
Gillian C Bell
Mission Health Personalized Medicine & Pharmacogenomics Program
Co-authored papers 3
Dan M Roden
Vanderbilt University Medical Center
Co-authored papers 3
Sony Tuteja
University of Pennsylvania Perelman School of Medicine
Co-authored papers 3
Release 1.2